Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-28 @ 1:36 PM
Study NCT ID:
NCT00038168
Status:
COMPLETED
Last Update Posted:
2012-08-01
First Post:
2002-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DM98-268
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None